The global women’s digital health market is estimated to be USD 3.22 billion in 2024 and is expected to reach USD 25.17 billion by 2035, with a CAGR of 20.56% during the forecast period 2025-2035. The market will grow as a result of growing emphasis on women's health and wellness, rising rates of chronic diseases among women, growing adoption of femtech solutions, rising demand for telemedicine and remote healthcare, and strategic alliances and partnerships.
The FemTech (female technology) sector, encompassing digital health solutions aimed at improving women’s wellness, menstrual health, fertility, pregnancy, menopause, and sexual health, has experienced a notable surge in innovation and investment. This momentum is instrumental in addressing previously underserved areas of women's health. In November 2023, AstraZeneca introduced Evinova, a health-tech venture designed to accelerate innovation across the life sciences sector. This initiative marks a significant advancement in the integration of technology into healthcare, allowing for more tailored approaches to women’s health. By leveraging advanced data analytics and digital platforms, Evinova aims to facilitate more inclusive clinical trials that take into account the unique physiological and psychological needs of women.
By type, the mobile apps segment accounted for the highest revenue-grossing segment in the global women’s digital health market in 2024 owing to the increasing adoption of smartphone-based health management solutions among women for tracking menstrual cycles, fertility, and overall wellness, as well as the growing availability of user-friendly health apps. For instance, HeraMed and FemBridge collaborated in March 2024 to create a comprehensive and scalable maternity care solution that would address the diverse demands of both healthcare providers and expectant moms. The goal of this partnership is to enhance the standard of care provided to expectant mothers by leveraging digital health technology. The alliance intends to improve communication and assistance along the maternity journey by using cutting-edge solutions, which will ultimately result in improved health outcomes. Additionally, the wearable devices segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for real-time health monitoring, fitness tracking, and ovulation prediction, driven by advancements in sensor technology and increased consumer interest in personalized health data.
By Application, the reproductive health segment accounted for the highest revenue-grossing segment in the global women’s digital health market in 2024 owing to the growing focus on women’s reproductive wellness, increased use of digital tools for fertility tracking, and the rising awareness of the importance of reproductive health among women. For instance, HeraMed and FemBridge teamed up in March 2024 to develop a complete and scalable maternity care system that meets the various needs of both healthcare providers and expectant moms. The goal of this partnership is to create a solution that uses digital health technology to improve the standard of care given to pregnant moms. Additionally, the pregnancy & nursing care segment is predicted to grow at the fastest CAGR during the forecast period owing to its increasing adoption of digital platforms that offer personalized guidance, remote consultations, and support for expectant and new mothers, catering to the growing need for accessible maternal care.
By end-user, the patients segment accounted for the highest revenue-grossing segment in the global women’s digital health market in 2024 owing to the increased utilization of digital health apps and platforms by women seeking convenient, self-managed healthcare solutions and personalized health insights. For instance, HeraMED introduced HeraCARE in June 2024 through specific GP clinics inside Telstra Health's Smart Connected Care ecosystem. In November 2023, HeraMED and Telstra Health's MedicalDirector platform struck a collaboration agreement. Additionally, the healthcare providers segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing adoption of digital health technologies by clinicians for better patient engagement, remote monitoring, and efficient management of women-specific health conditions.
North American region is anticipated to have the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, high adoption of digital health technologies, increasing investments in women's health solutions, and the presence of major FemTech companies. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rising awareness of women's health, increasing smartphone penetration, government initiatives promoting digital healthcare, and a growing middle-class population seeking advanced healthcare solutions. For instance, HeraMED and Joondalup Obstetrics and Gynecology Group (JOGG) inked a three-year partnership agreement in May 2023 with the goal of implementing HeraCare for 120 pregnancies per year.
This comprehensive research report focuses on the global and regional market size and forecasts from 2024 to 2035.
The FemTech (female technology) sector, encompassing digital health solutions aimed at improving women’s wellness, menstrual health, fertility, pregnancy, menopause, and sexual health, has experienced a notable surge in innovation and investment. This momentum is instrumental in addressing previously underserved areas of women's health. In November 2023, AstraZeneca introduced Evinova, a health-tech venture designed to accelerate innovation across the life sciences sector. This initiative marks a significant advancement in the integration of technology into healthcare, allowing for more tailored approaches to women’s health. By leveraging advanced data analytics and digital platforms, Evinova aims to facilitate more inclusive clinical trials that take into account the unique physiological and psychological needs of women.
By type, the mobile apps segment accounted for the highest revenue-grossing segment in the global women’s digital health market in 2024 owing to the increasing adoption of smartphone-based health management solutions among women for tracking menstrual cycles, fertility, and overall wellness, as well as the growing availability of user-friendly health apps. For instance, HeraMed and FemBridge collaborated in March 2024 to create a comprehensive and scalable maternity care solution that would address the diverse demands of both healthcare providers and expectant moms. The goal of this partnership is to enhance the standard of care provided to expectant mothers by leveraging digital health technology. The alliance intends to improve communication and assistance along the maternity journey by using cutting-edge solutions, which will ultimately result in improved health outcomes. Additionally, the wearable devices segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for real-time health monitoring, fitness tracking, and ovulation prediction, driven by advancements in sensor technology and increased consumer interest in personalized health data.
By Application, the reproductive health segment accounted for the highest revenue-grossing segment in the global women’s digital health market in 2024 owing to the growing focus on women’s reproductive wellness, increased use of digital tools for fertility tracking, and the rising awareness of the importance of reproductive health among women. For instance, HeraMed and FemBridge teamed up in March 2024 to develop a complete and scalable maternity care system that meets the various needs of both healthcare providers and expectant moms. The goal of this partnership is to create a solution that uses digital health technology to improve the standard of care given to pregnant moms. Additionally, the pregnancy & nursing care segment is predicted to grow at the fastest CAGR during the forecast period owing to its increasing adoption of digital platforms that offer personalized guidance, remote consultations, and support for expectant and new mothers, catering to the growing need for accessible maternal care.
By end-user, the patients segment accounted for the highest revenue-grossing segment in the global women’s digital health market in 2024 owing to the increased utilization of digital health apps and platforms by women seeking convenient, self-managed healthcare solutions and personalized health insights. For instance, HeraMED introduced HeraCARE in June 2024 through specific GP clinics inside Telstra Health's Smart Connected Care ecosystem. In November 2023, HeraMED and Telstra Health's MedicalDirector platform struck a collaboration agreement. Additionally, the healthcare providers segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing adoption of digital health technologies by clinicians for better patient engagement, remote monitoring, and efficient management of women-specific health conditions.
North American region is anticipated to have the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, high adoption of digital health technologies, increasing investments in women's health solutions, and the presence of major FemTech companies. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rising awareness of women's health, increasing smartphone penetration, government initiatives promoting digital healthcare, and a growing middle-class population seeking advanced healthcare solutions. For instance, HeraMED and Joondalup Obstetrics and Gynecology Group (JOGG) inked a three-year partnership agreement in May 2023 with the goal of implementing HeraCare for 120 pregnancies per year.
This comprehensive research report focuses on the global and regional market size and forecasts from 2024 to 2035.
Report Scope:
- Base Year: 2024
- Forecast Period: 2025-2035
- Study Coverage
- Market Forecast by Type, Application, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Segmentation: Women’s Digital Health Market Report 2024 - 2035
Women’s Digital Health Market Analysis & Forecast by Type 2024 - 2035 (Revenue USD Bn)
- Mobile Apps
- Wearable Device
- Diagnostic Tools
- Others
Women’s Digital Health Market Analysis & Forecast by Application 2024 - 2035 (Revenue USD Bn)
- Reproductive Health
- Pregnancy & Nursing Care
- Pelvic Care
- General Healthcare & Wellness
Women’s Digital Health Market Analysis & Forecast by End-User 2024 - 2035 (Revenue USD Bn)
- Patients
- Healthcare Providers
- Others
Women’s Digital Health Market Analysis & Forecast by Region 2024 - 2035 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Women’s Digital Health Market: Type Estimates & Trend Analysis
8. Women’s Digital Health Market: Application Estimates & Trend Analysis
9. Women’s Digital Health Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Women’s Digital Health Market
12. Europe Global Women’s Digital Health Market
13. Asia Pacific Global Women’s Digital Health Market
14. Latin America Global Women’s Digital Health Market
15. MEA Global Women’s Digital Health Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Clue
- Flo Health
- Maven Clinic
- Elvie
- Willow
- Ava Science
- Oura Health
- MyFLO
- Kindbody
- Kegels
- Babygaga
- Tia Health
- Nurture
- PillPack by Amazon Pharmacy
- Livia
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | December 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 3.22 Billion |
| Forecasted Market Value ( USD | $ 25.17 Billion |
| Compound Annual Growth Rate | 20.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
